Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 627

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 627
---
ice Capital, LLC. Armistice Capital, LLC beneficially owns an aggregate 
 of up to 1,352,681 shares of common stock and shares that may be acquired pursuant to warrants                 |

419

| (2) | Based on information set forth in the Schedule 13G filed with the SEC on February 14, 2023 by CBI USA,                                                                                                                                            
 Inc. (“CBI USA”) reporting that: (i) CBI USA beneficially owns 656,941 shares of common stock, consisting of 618,214 outstanding shares directly held, plus an additional 38,727 shares that may be acquired pursuant to warrants that are        
 exercisable within 60 days of May 15, 2025; (ii) CBI Co. is deemed to beneficially own 721,111 shares of common stock, consisting of the shares of common stock directly held or acquirable by CBI USA, its subsidiary, as described in (i), plus 
 55,871 outstanding shares directly held and an additional 8,299 shares that may be acquired pursuant to warrants that are exercisable within 60 days of May 15, 2025; and (iii) Daehan Green Power Corporation owns 100,409 outstanding shares    
 directly held. The address of CBI USA is 3000 Western Avenue, Suite 400, Seattle, Washington 98121.                                                                                                                                               |

| (3) | Based on information set forth in Schedule 13G filed with the SEC on February 12, 2024. |

| (4) | Consists of (i) 60,811 shares of common stock held by Mr. Philips, (ii) 34,654 shares held by Whetstone                                                                                                                       
 Ventures LLC for which Mr. Philips has shared voting rights and dispositive power and (iii) 337,643 shares of common stock issuable upon exercise of outstanding options that are exercisable within 60 days of May 15, 2025. |

| (5) | Consists of (i) 16,880 shares of common stock and (ii) 177,242 shares of common stock issuable upon exercise of 
 outstanding options that are exercisable within 60 days of May 15, 2025.                                        |

| (6) | Based on information set forth in Form 4 filed with the SEC on May 2, 2024. Consists of                                                                                                                                         
 (i) 17,206 shares of common stock